BT's investments boss Martyn Wild exits
Martyn Wild, BT Financial Group's chief investments officer, has parted ways with the company after his position became "untenable."
Sarah Thompson, Street Talk Editor
Sarah Thompson writes on Business specialising in Banking & Finance, Private Equity, Investment Banking, Equity Capital Markets, Media, Energy and Infrastructure. Based in our Sydney office, Sarah is a Street Talk editor
MOST RECENT ARTICLES
Fortescue's focus on debt to crimp dividends near term
Increased shareholder returns at Fortescue Metals Group are looking less likely in the near term.
Future Fund, AustralianSuper lead bumper market flows
The Future Fund is making changes in its mammoth Australian equities portfolio and has shifted more than $1 billion from one of its managers, sources told Street Talk.
PE head across ditch for Mainland Poultry fight
Australian private equity firms have had plenty of success across the Tasman.
Advisers, lawyers spar on Latitude Financial Services IPO
It's the biggest float on the radar of bankers and lawyers over the next 18 months, and noone wants to miss the boat.
Ups and Downers of underwriting the big trades
Fresh from the high of securing sole underwriting rights to Downer $1.011 billion rights issue - an $18.5 million job on the equity raising ...
Citi in $175m Evolution Mining block trade
Citi's equities desk was in the market with a $175 million block trade in gold producer Evolution Mining on Thursday afternoon.
Downer shortfall auction fails to fly, red Friday pending
Fund managers that did not follow their money into Downer's $1.011 billion equity raising are expected to receive nothing for their rights.
Tabcorp chairman Dwyer among six appointments to Takeovers Panel
The federal government has made six new appointments to the prestigious Takeovers Panel.
TFS Corp: the big short you can't short
Australia's community of short sellers is ablaze after US based research unit Glaucus Research published its $0.00 price target on TFS Corpo...
Marijuana play Creso Pharma raises $5.6 million
Medicinal cannabis company Creso Pharma has raised $5.6 million with the help of EverBlu Capital.
Trade buyer weighs final iNova bid, First Pharma raises capital
An eleventh hour push by a trade buyer is upping the ante for two private equity firms in the fight for Valeant-owned iNova Pharmaceuticals.
JPMorgan elevates Brook Campbell-Crawford
JPMorgan has informed employees Brook Campbell-Crawford will take over lead coverage of the building materials, paper and packaging and chem...
Wilsons, UBS in market for Collins Foods
Stockbrokers UBS and Wilsons are seeking to raise $54.5 million for ASX-listed fast food store owner Collins Foods.
Brokers up in arms as Pershing plots options retreat
The local options market is set to be dealt a large blow as Pershing lays the groundwork to retreat from clearing riskier trades.
AMP Capital in late play for Endeavour Energy
AMP Capital is believed to be in talks with Macquarie Group's infrastructure arm about co-investing in NSW's up-for-sale electricity distrib...
First cut is deep for Downer
The hard work has only just begun for Downer boss Grant Fenn.
UBS kicks off $268m Downer EDI shortfall auction
Downer EDI shareholders show the company what they think of its planned Spotless Group purchase.
Private party goes public at First Pharma
Sometimes all it takes is a backdoor listing to get the band back together.
EY chief Tony Johnson kicks off leadership reshuffle
EY boss Tony Johnson has made a few debits and credits to his leadership team.
More
